0000899243-22-008057.txt : 20220228
0000899243-22-008057.hdr.sgml : 20220228
20220228160047
ACCESSION NUMBER: 0000899243-22-008057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220224
FILED AS OF DATE: 20220228
DATE AS OF CHANGE: 20220228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barclay Alec
CENTRAL INDEX KEY: 0001734339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 22689192
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-24
0
0001492674
T2 Biosystems, Inc.
TTOO
0001734339
Barclay Alec
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Operations Officer
Common Stock
2021-02-24
4
M
0
168488
A
247633
D
Common Stock
2021-02-24
4
F
0
88878
0.4488
D
158755
D
Restricted Stock Units
2022-02-24
4
M
0
168488
0.00
D
Common Stock
168488
336976
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
88,878 shares of common stock were automatically withheld at vesting to cover required tax withholding.
On February 24, 2021 the reporting person was granted 505,464 RSU's that vest in three equal annual installments commencing on February 24, 2022.
/s/ John Sprague, Attorney-in-fact
2022-02-28